Healthcare

Share

Facebook Twitter Linkedin

Sirona Biochem Corp (TSXV:SBM)

0.08 CAD

0.000 0.000%

Last Updated at: 2024-10-08T16:01:00Z

Risk Disclaimer SBM chart by TradingView

Back to TSXV:SBM

Risk Disclaimer SBM chart by TradingView

Sponsored Reports

Loading...

Previous Close (in CAD)	0.08
Change	0.000 0.000%
52 W H/L (in CAD)	0.215/0.065
EBITDA (in CAD)	-2.065M
PE Ratio	--
Volume	5
Diluted Eps TTM	-0.01

Total Assets (in CAD)	1.291M
Total Liabilities (in CAD)	1.076M
Revenue TTM (in CAD)	0.084M
Cash (in CAD)	0.422M
Market Cap (in CAD)	29.006 M
Revenue Per Share TTM	--
Gross Profit TTM (in CAD)	0.622M

Summary

---

Income Statement

Balance Sheet

Change in Cash

Operating Cash

Sirona Biochem Corp

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

595 Burrard Street, Vancouver, BC, Canada, V7X 1L4

604 641 4466

https://www.sironabiochem.com

Key Executives

Sr. No.	Name	Title	Year Born
1.	Dr. Howard J. Verrico M.D., Ph.D.	Founder, Chairman, CEO & Sec.	1961
2.	Mr. Christopher D. Hopton C.G.A., C.P.A.	CFO & Director	1966
3.	Dr. Géraldine Deliencourt-Godefroy Ph.D.	Chief Scientific Officer & Director	NA
4.	Ms. Michelle Seltenrich MBA	VP of Operations	NA
5.	Dr. Brett A. Premack Ph.D.	Scientific Consultant	NA

Peers

Sector: Healthcare

Industry: Biotechnology

Company	Change (CAD)	Price (CAD)	Trailing PE(x)	Forward PE(x)	Price Sales TTM(x)	Price to Book Value(x)	Enterprise Value to Revenue(x)	Enterprise Value to EBITDA(x)
NGEN NervGen Pharma Corp	-0.020 0.830%	2.43	0.000	0.000	0.000	29.478	0.000	-6.948
ARCH Arch Biopartners Inc	-0.100 5.291%	1.92	0.000	0.000	37.823	0.000	53.055	-28.103
MIR MedMira Inc	0.000 0.000%	0.09	0.000	0.000	170.457	0.000	189.937	-48.737
TTI Thiogenesis Therapeutics Corp.	0.000 0.000%	0.67	0.000	0.000	0.000	11.863	0.000	-163.079

• Income Statement
• Balance Sheet
• Cash Flow

Income Statement

(Currency in CAD)

Breakdown	31-10-2022	31-10-2021	31-10-2020	31-10-2019	31-10-2018
Income Before Tax	-3.552M	-2.312M	-4.141M	-4.556M	-1.153M
Minority Interest	-	-	-	-	-
Net Income	-3.558M	-2.306M	-4.134M	-4.55M	-1.273M
Selling General Administrative	2.673M	1.401M	2.957M	3.341M	1.276M
Gross Profit	-	-	-	0.136M	1.279M
Reconciled Depreciation	0.009M	0.009M	0.01M	-	0M
Ebit	-3.39M	-2.134M	-3.995M	-4.199M	-0.856M
Ebitda	-3.516M	-2.299M	-4.118M	-4.439M	-0.926M
Depreciation And Amortization	-	-	-	-	-
Operating Income	-3.537M	-2.297M	-4.17M	-4.469M	-0.945M
Other Operating Expenses	-	-	-	-	-
Interest Expense	0.027M	0.003M	0.013M	0.117M	0.227M
Tax Provision	0.006M	-0.006M	-0.007M	-0.006M	0.12M
Interest Income	-	-	0.041M	-	-
Net Interest Income	-0.027M	-0.003M	0.028M	-0.117M	-0.227M
Income Tax Expense	0.006M	-0.006M	-0.007M	-0.006M	0.12M
Total Revenue	0.672M	0.268M	0.106M	0.136M	1.279M
Total Operating Expenses	4.209M	2.565M	4.276M	4.605M	2.223M
Cost Of Revenue	-	-	-	-	0.057M
Total Other Income Expense Net	0.013M	-0.012M	0.002M	0.03M	0.018M
Net Income From Continuing Ops	-3.558M	-2.306M	-4.134M	-4.55M	-1.273M
Net Income Applicable To Common Shares	-3.558M	-2.306M	-4.134M	-4.55M	-1.273M

Balance Sheet

(Currency in CAD)

Breakdown	31-10-2022	31-10-2021	31-10-2020	31-10-2019	31-10-2018
Total Assets	1.291M	1.287M	2.137M	4.257M	0.771M
Intangible Assets	-	-	-	-	-
Other Current Assets	-	-	-	-	-
Total Liab	1.076M	1.384M	2.09M	2.067M	3.031M
Total Stockholder Equity	0.215M	-0.097M	0.047M	2.19M	-2.261M
Other Current Liab	0.175M	0.106M	0.106M	0.102M	0.151M
Common Stock	34.487M	31.213M	29.079M	28.523M	20.397M
Capital Stock	34.487M	31.213M	29.079M	28.523M	20.397M
Retained Earnings	-41.358M	-37.8M	-35.493M	-31.36M	-26.81M
Good Will	-	-	-	-	-
Other Assets	-	-	-	-	-
Cash	0.422M	0.778M	1.536M	3.735M	0.339M
Cash And Equivalents	-	-	-	-	-
Total Current Liabilities	0.865M	0.741M	1.03M	0.92M	1.856M
Current Deferred Revenue	-	-	-	-	-
Net Debt	0.007M	-	-	-	1.995M
Short Term Debt	-	-	-	0.468M	1.378M
Short Long Term Debt	0.338M	0.301M	0.264M	0.468M	1.378M
Short Long Term Debt Total	-	-	-	-	-
Other Stockholder Equity	-0.224M	-0.061M	-0.102M	-0.011M	-0.012M
Property Plant Equipment	0.019M	0.028M	0.037M	-	-
Total Current Assets	1.272M	1.26M	2.1M	4.257M	0.771M
Long Term Investments	-	-	-	-	-
Short Term Investments	-	-	-	0.001M	0.001M
Net Receivables	0.797M	0.443M	0.496M	0.457M	0.304M
Long Term Debt	0.091M	0.469M	0.85M	0.943M	0.956M
Inventory	-	-	-	-	-
Accounts Payable	0.316M	0.297M	0.621M	0.314M	0.292M
Accumulated Other Comprehensive Income	-	-	-	-	-
Non Currrent Assets Other	-	-	-	0M	0M
Non Current Assets Total	0.019M	0.028M	0.037M	0M	0M
Capital Lease Obligations	0.041M	0.081M	0.127M	0.138M	0.176M
Long Term Debt Total	-	-	-	-	-

Cash Flow

(Currency in CAD)

Breakdown	31-10-2022	31-10-2021	31-10-2020	31-10-2019	31-10-2018
Investments	-	-	-0.047M	-	0M
Total Cashflows From Investing Activities	-	-	-0.047M	-0.047M	-0.047M
Total Cash From Financing Activities	2.037M	1.45M	-0.046M	6.964M	0.662M
Net Income	-3.558M	-2.306M	-4.134M	-4.55M	-1.273M
Change In Cash	-0.356M	-0.758M	-2.199M	3.396M	0.067M
Begin Period Cash Flow	0.778M	1.536M	3.735M	0.339M	0.272M
End Period Cash Flow	0.422M	0.778M	1.536M	3.735M	0.339M
Total Cash From Operating Activities	-2.178M	-2.158M	-2.112M	-3.559M	-0.593M
Depreciation	0.009M	0.009M	0.01M	0.01M	0.01M
Other Cashflows From Investing Activities	-	-	-	-	-
Dividends Paid	-	-	-	-	-
Change To Inventory	-	-	-	-	-
Sale Purchase Of Stock	-	-	-	-	-
Other Cashflows From Financing Activities	-	-	-	-	-
Capital Expenditures	0M	0M	0.047M	0.047M	0.047M
Change In Working Capital	-0.295M	-0.198M	0.393M	0M	0.364M
Other Non Cash Items	0.196M	-	0.002M	0.025M	0.243M
Free Cash Flow	-2.178M	-2.158M	-2.159M	-3.559M	-0.654M

No data found

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

• Top Gainer
• Top Loser